Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis [Phase 2]

View source ↗

Summary

A Phase II clinical trial update indicating that D-2570 is being studied for efficacy and safety in active psoriatic arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: PsA (Psoriatic Arthritis) | Phase 2 | Status: RECRUITING